Advertisement

Orthopedic devices maker Orthofix makes big strides in its profit margin expansion program, but suffers setbacks in sales due to obstacles in international markets.

Orthofix logo

Medical device maker Orthofix (NSDQ:OFIX) posted huge growth for its bottom line in both the 4th quarter and full year of 2012, but reported sliding sales and projected slow growth for the year ahead.

The Lewisville, Texas-based company posted profit of $20.5 million, or $1.04 per diluted share, on sales of $112 million during the 3 months ended Dec. 31, 2012.

Advertisement
Advertisement